Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Identifying the molecular mechanisms behind oncolytic viral resistance in tumour cells.

FY 2016-17

Summary
Existing cancer treatments display a limited ability to selectively target tumour cells, leading to highly toxic effects on normal cells. Oncolytic viruses (OVs) have been used as an alternative treatment strategy since they can target these tumour cells, leaving normal cells unharmed. Current research suggests that this selectivity is based on exploiting the defective anti-viral response in cancer cells that is intact in healthy cells. However, some tumours are resistant to the viral therapy, limiting its ability to destroy the tumour. At present, there is no known cause for this resistance. My project will help to identify potential underlying causes by investigating the effects that different cancer-associated gene modifications have on the sensitivity of tumour cells to OVs. The results from this study will help in developing viral therapies that successfully eliminate tumours, with minimal toxicity to the rest of the body.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
367068
Name
Chen Ashley
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying the molecular mechanisms behind oncolytic viral resistance in tumour cells.
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Amirna; Cancer; Cell Culture; Crispr/Cas9; Gene Expression; Interferon; Molecular Biology; Viruses
Abstract
Existing cancer treatments display a limited ability to selectively target tumour cells, leading to highly toxic effects on normal cells. Oncolytic viruses (OVs) have been used as an alternative treatment strategy since they can target these tumour cells, leaving normal cells unharmed. Current research suggests that this selectivity is based on exploiting the defective anti-viral response in cancer cells that is intact in healthy cells. However, some tumours are resistant to the viral therapy, limiting its ability to destroy the tumour. At present, there is no known cause for this resistance. My project will help to identify potential underlying causes by investigating the effects that different cancer-associated gene modifications have on the sensitivity of tumour cells to OVs. The results from this study will help in developing viral therapies that successfully eliminate tumours, with minimal toxicity to the rest of the body.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chen, Ashley
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~